We observed higher TRAP expression in COPD and asthma as compared to control and we found that this increase may be triggered by RANKL and/or oxidative stress, though the functional consequences of this higher expression and activity remain to be determined. The gene discussed is ACP5; the disease is chronic obstructive pulmonary disease.